Articles published by Samsung BioepisFrom Samsung Bioepis
Via GlobeNewswire
From Samsung Bioepis
Via GlobeNewswire
From Samsung Bioepis
Via GlobeNewswire
Samsung Bioepis Secures US License Date for SB17, a Proposed Biosimilar to Stelara®
November 30, 2023
From Samsung Bioepis
Via GlobeNewswire
Samsung Bioepis Partners with Sandoz to Commercialize Ustekinumab Biosimilar Candidate
September 11, 2023
From Samsung Bioepis
Via GlobeNewswire
Samsung Bioepis & Organon Announce Topline Results from Interchangeability Study of SB5 Humira Biosimilar
August 01, 2023
From Samsung Bioepis
Via GlobeNewswire
Tickers
OGN
From Samsung Bioepis
Via GlobeNewswire
Samsung Bioepis Releases 2023 Sustainability Report
June 30, 2023
From Samsung Bioepis
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|